StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Alnylam Pharma (ALNY) Granted Accelerated Assessment of Patisiran by EMA
November 13, 2017 7:33 AM
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
Next Articles
Alnylam Pharma (ALNY) Prices 5.6M Share Common Offering at $125/Sh
November 14, 2017 5:48 AM
European Medicines Agency (EMA) Grants Alnylam Accelerated Assessment of Patisiran for Patients with Hereditary ATTR (hATTR) Amyloidosis
November 13, 2017 7:30 AM